Previous studies have found that systemic inflammatory markers such as C reactive protein and airway cytokines (tumor necrosis factor-α, IL-1, IL-8) are increased in patients with bronchiectasis [32–34]. The gene discussed is CXCL8; the disease is bronchiectasis.